Page 276 - PROGRAMME2018

P-473 Effect of N-acetyl cysteine on expression of oxidation-reduction genes during implantation window in Recurrent Implantation Failure: a double blinded randomized placebo controlled trial, phase II
B. Salmani1, E. Teimoorbakhsh2, M. Shahhoseini1, A.A. Akhlaghi3, A. Moeini4,5, P. Afsharian1
1Reproductive Biomedicine Research Center- Royan Institute for Reproductive Biomedicine- ACECR-, Department of Genetics, Tehran, Iran
2Faculty of Science- East Tehran Branch- Islamic Azad University-, Department of Genetics, Tehran, Iran
3Reproductive Biomedicine Research Center- Royan Institute for Reproductive Biomedicine- ACECR-, Department of Epidemiology and Reproductive Health, Tehran, Iran
4Reproductive Biomedicine Research Center- Royan Institute for Reproductive Biomedicine- ACECR-, Department of Endocrinology and Female Infertility, Tehran, Iran
5Faculty of Medicine- Tehran University of Medical Science, Department of Obstetrics and Gynecology, Tehran, Iran
P-474 Can we increase the Live-Birth predictive value of early beta-hCG level: A simple proposal for clinical practice.
P. Arvis1, A. Guivarch-Leveque1, M. Bidet1, F. Jaffre1, P. Lehert2 1Clinique La Sagesse, Amp Department, Rennes, France
2The University of Melbourne and Melbourne IVF, Faculty of Medicine- Psychiatry Department, East Melbourne VIC, Australia
P-475 Mucin1 (MUC1) localization and quantitative study in luminal epithelium during implantation window
F. Wu1, Y. Liu1, D. Mao1, X. Chen1, H. Xu1, T.C. Li1, C.C. Wang1
1Department of Obstetrics and Gynaecology- The Chinese University of Hong Kong- Shatin Hong Kong, Obstetrics and Gynaecology, Hong Kong
P-476 Capturing the physiological characteristics of early pregnancy using wrist worn wearables
M. Shilih1, B. Goodale2, L. Falco2, F. Kuebler2, F. Dammeier2, B. Leeners1
1University Hospital Zurich, Department of Reproductive Endocrinology, Zurich, Switzerland 2Ava AG, Research and Development, Zurich, Switzerland
P-477 What is the real length of the window of implantation (WOI) in humans?
A. Rincon1, M. Clemente-Císcar2, E. Gomez1, C. Marin1, D. Valbuena3, C. Simon4,5,6,7 1Igenomix SL, Endometrial Receptivity Department, Valencia, Spain
2Igenomix SL, Bioinformatics Department, Valencia, Spain
3Igenomix SL, Medical Department, Valencia, Spain
4Igenomix SL, Scientific Director, Valencia, Spain
5University of Valencia / INCLIVA, Department of Obstetrics and Gynecology, Valencia, U.S.A. 6Stanford University, Department of Obstetrics and Gynecology, California, U.S.A.
7Baylor College of Medicine, Department of Obstetrics and Gynecology, Texas, U.S.A.
276